Dr Bettina Werle, Head of Protein and Expression System Engineering Unit at BIOASTER, will be attending the Virus-Like Particle & Nanoparticle Vaccines congress, in Bern as of today. She will...
Discover another Technologies designed by BIOASTER: ANOXIC platform! Based at BIOASTER Paris’s premises, the ANOXIC platform is a set of expertise and equipment specially developed to handle anaerobic strains of microbiota...
Bioaster will be at «The Human Microbiome» conference, with one poster presenting LUMI-seq™, our method for reconstructing near full-length 16S rRNA genes using Illumina short reads. The Human microbiome conference,...
A new publication about BIOFILM has been released on August 29th on Nature/Scientific reports. Entitled “A steam-based method to investigate biofilm”, it has been co-written by Régis Villet from BIOASTER....
Automation of 16S Metagenomic Sequencing Library Preparation Microbial composition analysis by 16S rRNA sequencing has become a standard practice. The preparation before the sequencing remains tedious and time-consuming. Automated library...
June 26th&27th 2018, BIOASTER invited to join a Brazilian public-private initiative network. The University of Sao Paulo (USP), private organizations led by the Brazilian health company Eurofarma, public funders like...
BIOASTER is proud to be “co-author” of this paper in Nature Communications “A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection” Full-text access by clicking here.
BIOASTER participates in the Pasteur course Christophe Vedrine (Biological Microsystems and Advanced Optics engineering unit) and Fabrice Porcheray (Immunomonitoring Unit) had the opportunity to give a presentation as part of...
New publication in Vaccine May 2018, based on an innovative platform on nanoparticles. The Protein & Expression system engineering Unit has developed a new nanoparticle carrier system that enables simultaneous...
BIOASTER announces today, the initiation of a collaborative project aiming at improving the safety and immunogenicity of adjuvants included in the composition of new candidate vaccines. MOSAIC (MOlecular Signatures of...
This morning, BIOASTER welcomed the Singapore Ambassador to France, Mr Zainal Arif MANTAHA, for a very interesting meeting. Dr. Cyril Guyard leads the visit of our HQ.
By continuing browsing this website, you accept the use of cookies or other tracers for statistics of visits to optimize the functionality of the site, and or privacy policy. AcceptRejectRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
